Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesFelix Bayerl, Jan P. Böttcher, Sebastian Lacher et al.|Immunity|2023Cited by 176
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Anna C. Obenauf, Guillem Estivill et al.|Nature|2024Cited by 122